SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-003444
Filing Date
2020-01-13
Accepted
2020-01-13 16:01:42
Documents
2
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1598
2 EX-24 ex-24.htm EX-24 9370
  Complete submission text file 0001104659-20-003444.txt   12347
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY ST., SUITE 300 CAMBRIDGE MA 02139
Business Address
Coughlin Christina M. (Reporting) CIK: 0001799032 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38586 | Film No.: 20523858